Firstly, immunodeficient (SCID) mice challenged subcutaneously (s.c.) with FRα-expressing human ovarian carcinoma cells, were treated with human peripheral blood lymphocytes (PBLs) and MOv18 IgE or IgG1 antibodies i.v. [122]. This evidence concerns the gene FOLR1 and ovarian carcinoma.